LRRC8B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.187200E-01
Normal-vs-Stage2
9.953200E-01
Normal-vs-Stage3
1.127620E-01
Normal-vs-Stage4
1.945840E-01
Stage1-vs-Stage2
6.118800E-01
Stage1-vs-Stage3
9.676300E-02
Stage1-vs-Stage4
2.737600E-01
Stage2-vs-Stage3
1.452440E-01
Stage2-vs-Stage4
7.558200E-02
Stage3-vs-Stage4
2.533800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.607600E-01
Normal-vs-AfricanAmerican
4.185000E-01
Normal-vs-Asian
7.804800E-01
Caucasian-vs-AfricanAmerican
2.235600E-01
Caucasian-vs-Asian
8.498600E-01
AfricanAmerican-vs-Asian
2.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.419600E-01
Normal-vs-Female
9.842400E-01
Male-vs-Female
4.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.588600E-01
Normal-vs-Age(41-60Yrs)
7.365800E-01
Normal-vs-Age(61-80Yrs)
7.390000E-01
Normal-vs-Age(81-100Yrs)
3.094600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.760400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.652600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.625800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.804000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.372300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.928020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.704000E-01
Normal-vs-Daily Drinker
5.671600E-01
Normal-vs-Weekly Drinker
4.703000E-01
Normal-vs-Occasional Drinker
9.862200E-01
Normal-vs-Social Drinker
9.884000E-01
Non Drinker-vs-Daily Drinker
3.397800E-01
Non Drinker-vs-Weekly Drinker
3.133600E-01
Non Drinker-vs-Occasional Drinker
7.347000E-01
Non Drinker-vs-Social Drinker
7.857800E-01
Daily Drinker-vs-Weekly Drinker
9.107400E-01
Daily Drinker-vs-Occasional Drinker
2.821400E-01
Daily Drinker-vs-Social Drinker
3.089000E-01
Weekly Drinker-vs-Occasional Drinker
2.668600E-01
Weekly Drinker-vs-Social Drinker
2.712000E-01
Occasional Drinker-vs-Social Drinker
9.565000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.147220E-01
Normal-vs-Grade 2
9.701800E-03
Normal-vs-Grade 3
1.086420E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.579900E-02
Grade 1-vs-Grade 3
1.433820E-01
Grade 1-vs-Grade 4
1.147220E-01
Grade 2-vs-Grade 3
9.020600E-01
Grade 2-vs-Grade 4
9.701800E-03
Grade 3-vs-Grade 4
1.086420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.461000E-01
Normal-vs-NonDiabetic
8.447400E-01
Diabetic-vs-NonDiabetic
2.473600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.773400E-01
Normal-vs-NoPancreatitis
7.713800E-01
Pancreatitis-vs-NoPancreatitis
6.238400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.913200E-01
Normal-vs-N1
9.860800E-01
N0-vs-N1
3.358600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.963200E-01
Normal-vs-TP53-NonMutant
9.591200E-01
TP53-Mutant-vs-TP53-NonMutant
4.779000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
